CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells

MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tiss...

Full description

Saved in:
Bibliographic Details
Published inThe FASEB journal Vol. 24; no. 7; pp. 2292 - 2300
Main Authors Rom, Slava, Rom, Inna, Passiatore, Giovanni, Pacifici, Marco, Radhakrishnan, Sujatha, Del Valle, Luis, Piña-Oviedo, Sergio, Khalili, Kamel, Eletto, Davide, Peruzzi, Francesca
Format Journal Article
LanguageEnglish
Published United States The Federation of American Societies for Experimental Biology 01.07.2010
Subjects
Online AccessGet more information

Cover

Loading…
Abstract MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.--Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D., Peruzzi, F. CCL8/MCP-2 is a target for mir-146a in HIV-1 infected human microglial cells.
AbstractList MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.--Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D., Peruzzi, F. CCL8/MCP-2 is a target for mir-146a in HIV-1 infected human microglial cells.
MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation, proliferation, and apoptosis. Mir-146a is thought to be involved in the regulation of the innate immune response, and its expression is increased in tissues associated with chronic inflammation. Among the predicted gene targets for mir-146a, the chemokine CCL8/MCP-2 is a ligand for the CCR5 chemokine receptor and a potent inhibitor of CD4/CCR5-mediated HIV-1 entry and replication. In the present study, we have analyzed changes in the expression of mir-146a in primary human fetal microglial cells upon infection with HIV-1 and found increased expression of mir-146a. We further show that CCL8/MCP-2 is a target for mir-146a in HIV-1 infected microglia, as overexpression of mir-146a prevented HIV-induced secretion of MCP-2 chemokine. The clinical relevance of our findings was evaluated in HIV-encephalitis (HIVE) brain samples in which decreased levels of MCP-2 and increased levels of mir-146a were observed, suggesting a role for mir-146a in the maintenance of HIV-mediated chronic inflammation of the brain.
Author Piña-Oviedo, Sergio
Peruzzi, Francesca
Passiatore, Giovanni
Del Valle, Luis
Khalili, Kamel
Pacifici, Marco
Radhakrishnan, Sujatha
Rom, Slava
Rom, Inna
Eletto, Davide
Author_xml – sequence: 1
  fullname: Rom, Slava
– sequence: 2
  fullname: Rom, Inna
– sequence: 3
  fullname: Passiatore, Giovanni
– sequence: 4
  fullname: Pacifici, Marco
– sequence: 5
  fullname: Radhakrishnan, Sujatha
– sequence: 6
  fullname: Del Valle, Luis
– sequence: 7
  fullname: Piña-Oviedo, Sergio
– sequence: 8
  fullname: Khalili, Kamel
– sequence: 9
  fullname: Eletto, Davide
– sequence: 10
  fullname: Peruzzi, Francesca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20181935$$D View this record in MEDLINE/PubMed
BookMark eNo1j81KAzEYRYNU7I_uXGteIO2XZPJNspTB2sKIgtbtkKZJTZmfkmkXvr0D1dXlcg8H7pSM2q71hNxzmHMwuAiHORjGM6lAXpEJVxIYaoQRmYA2giFKPSbTvj8AAAeON2QsgGtupJqQsihKvXgt3pmgsaeWnmza-xMNXaJNTIMXLY0tXa2_GGexDd6d_I5-nxvbDoBL3b6OtqbO13V_S66DrXt_95czslk-fxYrVr69rIunkrlMoWQOMxeCzbULYpdL3GZGSeUlV97k2VBR5Sj8FjznToOW1nDjpYDg0TktxYw8XLzH87bxu-qYYmPTT_V_awAeL0CwXWX3KfbV5mNY5QCg4CDFL_IpVZk
CitedBy_id crossref_primary_10_1186_s13024_018_0285_1
crossref_primary_10_1186_s12974_023_02856_0
crossref_primary_10_12688_wellcomeopenres_14188_1
crossref_primary_10_17816_RCF192145_174
crossref_primary_10_1038_s41598_020_67460_1
crossref_primary_10_1016_j_brainresbull_2018_03_007
crossref_primary_10_4161_epi_5_7_12762
crossref_primary_10_1007_s11064_013_1209_7
crossref_primary_10_1186_1471_2156_13_72
crossref_primary_10_3390_genes15050574
crossref_primary_10_1155_2013_186872
crossref_primary_10_1186_s12865_017_0237_5
crossref_primary_10_3390_vaccines11020264
crossref_primary_10_1016_j_molmed_2011_06_009
crossref_primary_10_1186_s12974_022_02627_3
crossref_primary_10_2200_S01171ED1V01Y202202BME062
crossref_primary_10_1097_QAD_0b013e32834b95bf
crossref_primary_10_1007_s00705_017_3226_3
crossref_primary_10_3389_fnmol_2020_00090
crossref_primary_10_1099_jgv_0_001065
crossref_primary_10_1002_jcp_24254
crossref_primary_10_3390_cells12222591
crossref_primary_10_3389_fimmu_2022_959729
crossref_primary_10_1007_s12035_013_8400_3
crossref_primary_10_3390_pathogens10081018
crossref_primary_10_1002_iub_2296
crossref_primary_10_1074_jbc_M115_675751
crossref_primary_10_3390_v10010013
crossref_primary_10_1111_j_1574_695X_2011_00894_x
crossref_primary_10_5301_jbm_5000194
crossref_primary_10_1002_iub_2222
crossref_primary_10_1007_s11481_019_09892_9
crossref_primary_10_1007_s13311_013_0207_4
crossref_primary_10_1016_j_neuro_2012_02_013
crossref_primary_10_1007_s13365_011_0046_1
crossref_primary_10_1002_ijc_28141
crossref_primary_10_1038_s41435_018_0036_x
crossref_primary_10_1016_j_virol_2015_01_016
crossref_primary_10_1080_15287394_2011_618973
crossref_primary_10_1007_s11481_018_9779_4
crossref_primary_10_1016_j_biopha_2018_12_121
crossref_primary_10_1016_j_biopha_2017_09_138
crossref_primary_10_1016_j_jinf_2013_05_003
crossref_primary_10_1111_hiv_12822
crossref_primary_10_1016_j_bbrc_2011_05_153
crossref_primary_10_1016_j_jns_2020_117202
crossref_primary_10_3390_cells11040658
crossref_primary_10_1371_journal_pone_0081438
crossref_primary_10_1159_000533595
crossref_primary_10_1016_j_ejphar_2015_03_018
crossref_primary_10_1002_jcp_25131
crossref_primary_10_3390_ijms241612767
crossref_primary_10_1042_AN20130050
crossref_primary_10_1007_s13365_020_00834_3
crossref_primary_10_1016_j_pharep_2017_01_021
crossref_primary_10_1038_jcbfm_2015_154
crossref_primary_10_1002_glia_22363
crossref_primary_10_1002_mc_21937
crossref_primary_10_1089_aid_2017_0217
crossref_primary_10_1016_j_bbamcr_2011_06_012
crossref_primary_10_1182_blood_2012_08_452425
crossref_primary_10_1007_s00401_017_1803_x
crossref_primary_10_1016_j_genrep_2020_100956
crossref_primary_10_1007_s13277_013_0927_4
crossref_primary_10_1096_fj_13_232678
crossref_primary_10_1097_COH_0b013e3283497203
crossref_primary_10_1186_1756_8722_5_13
crossref_primary_10_3390_genes4010046
crossref_primary_10_1074_jbc_M114_633081
crossref_primary_10_1097_QAD_0b013e328352adca
crossref_primary_10_1016_j_canlet_2011_10_031
crossref_primary_10_1016_j_pneurobio_2016_01_005
crossref_primary_10_1371_journal_pone_0079926
crossref_primary_10_3389_fimmu_2020_00136
crossref_primary_10_3389_fncel_2021_785433
crossref_primary_10_1016_j_pneurobio_2015_05_003
crossref_primary_10_1038_s41598_019_55100_2
crossref_primary_10_1007_s11596_015_1414_5
crossref_primary_10_1177_1759091420981182
crossref_primary_10_1016_j_ijbiomac_2021_11_061
crossref_primary_10_3389_fmicb_2015_00967
crossref_primary_10_1016_j_brainresbull_2017_10_009
crossref_primary_10_1099_vir_0_041186_0
crossref_primary_10_1016_j_cyto_2013_01_020
crossref_primary_10_1155_2013_451248
crossref_primary_10_1093_brain_awv066
crossref_primary_10_1111_imr_12077
crossref_primary_10_1186_s43042_022_00232_w
crossref_primary_10_1186_s12974_015_0249_0
crossref_primary_10_1016_j_omto_2023_09_001
crossref_primary_10_1016_j_biopha_2018_12_103
ContentType Journal Article
DBID FBQ
CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1096/fj.09-143503
DatabaseName AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1530-6860
EndPage 2300
ExternalDocumentID 20181935
US201301862103
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: P01 NS030916
– fundername: NINDS NIH HHS
  grantid: P01 NS30916
– fundername: NIMH NIH HHS
  grantid: MH071162
– fundername: NIMH NIH HHS
  grantid: R01 MH079751
– fundername: NIMH NIH HHS
  grantid: R01 MH071162
– fundername: NIMH NIH HHS
  grantid: MH079751
GroupedDBID ---
-DZ
-~X
.55
0R~
0VX
123
18M
1OB
1OC
29H
2WC
33P
34G
39C
3O-
4.4
53G
5GY
5RE
85S
AAHHS
AANLZ
ABCUV
ABDNZ
ABEFU
ABJNI
ABOCM
ABPTK
ACCFJ
ACCZN
ACGFS
ACIWK
ACNCT
ACPOU
ACPRK
ACXQS
ACYGS
ADKYN
ADZMN
AEEZP
AEIGN
AENEX
AEQDE
AEQTP
AEUYR
AFDAS
AFFNX
AFFPM
AFMIJ
AFRAH
AGCDD
AI.
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
BFHJK
C1A
CS3
DCZOG
DU5
D~5
E3Z
EBS
EJD
F20
F5P
F9R
FBQ
FRP
HZ~
H~9
J5H
L7B
LATKE
LEEKS
MEWTI
MVM
NEJ
O9-
OHT
OVD
Q-A
RHF
RHI
RJQFR
ROL
SAMSI
SJN
SUPJJ
TEORI
TFA
TR2
TWZ
VH1
W8F
WH7
WHG
WOQ
WXSBR
X7M
XJT
XOL
XSW
Y6R
YBU
YCJ
YHG
YKV
YNH
YSK
Z0Y
ZA5
ZCA
ZE2
ZGI
ZXP
~KM
AHBTC
AITYG
AIZAD
BIYOS
CGR
CUY
CVF
ECM
EIF
H13
HGLYW
NPM
ID FETCH-LOGICAL-c4563-c64cffa78cf2d736b49535e315e9746b465762eb0e11c8083a919e320fe6cc832
ISSN 0892-6638
IngestDate Tue Aug 27 13:56:17 EDT 2024
Wed Dec 27 18:55:12 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4563-c64cffa78cf2d736b49535e315e9746b465762eb0e11c8083a919e320fe6cc832
OpenAccessLink https://europepmc.org/articles/pmc2887261
PMID 20181935
PageCount 9
ParticipantIDs pubmed_primary_20181935
fao_agris_US201301862103
PublicationCentury 2000
PublicationDate July 2010
PublicationDateYYYYMMDD 2010-07-01
PublicationDate_xml – month: 07
  year: 2010
  text: July 2010
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The FASEB journal
PublicationTitleAlternate FASEB J
PublicationYear 2010
Publisher The Federation of American Societies for Experimental Biology
Publisher_xml – name: The Federation of American Societies for Experimental Biology
References 17942673 - Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17016-21
18599350 - Trends Immunol. 2008 Aug;29(8):357-65
16885212 - Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
17060477 - J Exp Med. 2006 Oct 30;203(11):2519-27
8843093 - Neuroscience. 1996 Sep;74(1):283-92
17468766 - Nat Med. 2007 May;13(5):613-8
11115360 - Exp Mol Pathol. 2000 Dec;69(3):192-201
9468473 - J Biol Chem. 1998 Feb 20;273(8):4289-92
17162663 - J Neurovirol. 2006 Dec;12(6):472-91
10828541 - Neuroscience. 2000;97(3):591-600
16099643 - Curr Opin Genet Dev. 2005 Oct;15(5):563-8
17060945 - Nat Rev Cancer. 2006 Nov;6(11):857-66
11930329 - J Infect Dis. 2002 Apr 15;185(8):1174-8
17113784 - Semin Cancer Biol. 2007 Feb;17(1):65-73
8658171 - Science. 1996 Jun 28;272(5270):1955-8
11574916 - J Infect Dis. 2001 Oct 15;184(8):1015-21
17463290 - Science. 2007 Apr 27;316(5824):608-11
10550927 - Chem Immunol. 1999;72:7-29
17011485 - Dev Cell. 2006 Oct;11(4):441-50
15954144 - J Neurosci Res. 2005 Aug 1;81(3):436-46
8649512 - Nature. 1996 Jun 20;381(6584):667-73
14744438 - Cell. 2004 Jan 23;116(2):281-97
16236258 - Biochem Biophys Res Commun. 2005 Dec 2;337(4):1214-8
17923094 - Cell. 2007 Oct 5;131(1):146-59
18347435 - RNA Biol. 2007 Nov;4(3):131-7
17242365 - Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9
12941428 - Curr Opin Chem Biol. 2003 Aug;7(4):516-23
17622355 - PLoS One. 2007;2(7):e610
18291670 - Semin Cancer Biol. 2008 Apr;18(2):131-40
18381601 - J Cell Physiol. 2008 Sep;216(3):764-70
8558070 - J Leukoc Biol. 1996 Jan;59(1):67-74
18057241 - J Virol. 2008 Feb;82(4):1946-58
9115216 - J Biol Chem. 1997 May 2;272(18):11682-5
19021527 - Biochem Soc Trans. 2008 Dec;36(Pt 6):1211-5
1613466 - J Exp Med. 1992 Jul 1;176(1):59-65
15211354 - Nat Rev Genet. 2004 Jul;5(7):522-31
9655469 - J Neuroimmunol. 1998 Jun 1;86(1):20-9
11100124 - Nat Med. 2000 Dec;6(12):1380-7
19135886 - Cell. 2009 Jan 9;136(1):26-36
15944708 - Nature. 2005 Jun 9;435(7043):834-8
16146764 - Front Biosci. 2006;11:718-32
17463289 - Science. 2007 Apr 27;316(5824):604-8
19596990 - J Immunol. 2009 Aug 1;183(3):2150-8
8745241 - Neuropathol Appl Neurobiol. 1995 Dec;21(6):518-28
16061966 - Methods Mol Biol. 2005;304:49-70
17849003 - PLoS One. 2007;2(9):e873
15459663 - Nat Rev Mol Cell Biol. 2004 Oct;5(10):827-35
17712037 - Physiol Genomics. 2007 Nov 14;31(3):367-73
18801740 - J Biol Chem. 2008 Nov 14;283(46):31315-22
16009126 - Cell. 2005 Jul 15;122(1):6-7
15614608 - J Mol Histol. 2004 Aug;35(6):545-53
2322286 - Biochem Biophys Res Commun. 1990 Mar 30;167(3):904-9
References_xml
SSID ssj0001016
Score 2.3922906
Snippet MicroRNA-mediated regulation of gene expression appears to be involved in a variety of cellular processes, including development, differentiation,...
SourceID pubmed
fao
SourceType Index Database
Publisher
StartPage 2292
SubjectTerms Cells, Cultured
Chemokine CCL8 - antagonists & inhibitors
Encephalitis, Viral - pathology
Gene Expression Regulation - immunology
HIV Infections - etiology
HIV Infections - genetics
HIV Infections - immunology
HIV-1 - pathogenicity
Humans
Inflammation - virology
Microglia - virology
MicroRNAs - genetics
Title CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells
URI https://www.ncbi.nlm.nih.gov/pubmed/20181935
Volume 24
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swELdW0KS9ID7GYHzID3tDhiRO7PgRKkqZAIFKJ94qx3WqIJqiUSGxv353dkJDGdPYS5T4lMjy_XK-O98HId9yY2Iuk4Tx1GoWJ4lkilvF5DCOAxNZkQnMdz6_EN1-_P0muZm5sl12yTTbN7_-mFfyP1yFMeArZsm-g7PPH4UBuAf-whU4DNd_4nG7fYbB9eftSxZhZ3K95wO7XezguPjJQEBp9Gh0T3-AEecDr0DD9I35xhiLN7pDlzm67x-aeiqip3PYOz7aa07EHcw4APXu9KOeGzsty-ehS9DJC7Tnnb_0BCNey7KYUV0kYFElC5lJ0_eAx-ay9j3YWl6C9Zn6lgC1QPVJ0RVwZFM6Rr7v3SuxDXYUrvXtPvZmAAXOlT2YNjh4P3YsjLC8mPL1Tf5OnSuiXZNapCVTFIcX6NSpNmx0YFQ5ETCRg-Y0sFZ09SooH7mezFkfTgu5XiZLlflADz0WVsgHW66Sj76h6NMaOUNEHDg80OKBaurxQAEPtMYDLUr6Eg_U4YHO8EAdHj6Tfuf4ut1lVb8MZkAN5syI2OS5lqnJo6HkIsPY4cTyMLFgNcKjAOMysllgw9CkoHtrFSrLoyC3whgQ7etkoZyUdoNQNUwFD20MZBErI7XQWgcqkypPYZMwm2QDFmOgR7ATDfq9CM-_QzCOw4Bvki9-hQb3vl7KoF7Br29StsinGby2yWIOP6jdAW1vmu2SVufoatdx7DfkU0re
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CCL8%2FMCP-2+is+a+target+for+mir-146a+in+HIV-1-infected+human+microglial+cells&rft.jtitle=The+FASEB+journal&rft.au=Rom%2C+Slava&rft.au=Rom%2C+Inna&rft.au=Passiatore%2C+Giovanni&rft.au=Pacifici%2C+Marco&rft.date=2010-07-01&rft.eissn=1530-6860&rft.volume=24&rft.issue=7&rft.spage=2292&rft_id=info:doi/10.1096%2Ffj.09-143503&rft_id=info%3Apmid%2F20181935&rft_id=info%3Apmid%2F20181935&rft.externalDocID=20181935
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon